Has the Market Correction Made AbbVie Stock Cheap?
With the stock market down about 8% so far this year -- and briefly entering correction territory last week -- investors are on the lookout for shares of quality companies that have dropped into bargain territory. AbbVie's (NYSE: ABBV) stock, however, has been moving up rather than down so far in 2022. Is it a buy?
Before approaching the question of AbbVie's valuation directly, let's look at where the company plans to go over the next few years, as well as its recent performance.
Image source: Getty Images.
Source Fool.com
